Speaker: Jorge Castillo

0:50:34

Jorge Castillo - ArrowFx: Functional Programming for the masses

1:17:11

Jorge Castillo - Functional Android

0:32:59

Management of Waldenstrom disease: an update

0:01:19

Jorge Castillo: IMW 2019

0:04:39

Expanded access study of zanubrutinib in patients with Waldenström’s macroglobulinemia

0:03:10

A Phase II trial of loncastuximab tesirine in previously treated Waldenström's macroglobulinemia

1:03:30

Treatments, Trials, & Hope with Dr. Jorge Castillo, January 19, 2023

1:01:34

Full Video - Chairman Jorge Castillo speaks at 2017 Milken Institute Global Conference (Full Video)

0:05:30

Chairman Jorge Castillo Highlights from 2017 Milken Institute Global Conference

0:03:03

Outcomes following venetoclax monotherapy in patients with R/R WM in the real-world setting

0:02:54

Waldenström’s therapy: what's on the horizon?

0:03:20

MGUS and neuropathy: current understanding and unmet needs

0:03:03

The evolution of treatment patterns and prognostic biomarkers in Latin American CLL patients

0:42:50

Functional approach to Android architecture using Kotlin - Jorge Castillo

0:03:47

Palliative treatment of waldenström’s macroglobulinemia

0:57:33

2022 IWMF Ed Forum-Everything You Want to Know About BTK Inhibitors, Do's and Don'ts

0:03:49

Genomic landscape of Waldenström’s

0:04:36

Ulocuplumab & ibrutinib for CXCR4-mutated Waldenström's macroglobulinemia

0:04:52

Cost-effectiveness of zanubrutinib vs rituximab-based therapy in Waldenström’s macroglobulinemia

0:07:21

Somos Baltimore Latino Entrevista del dia con Jorge Castillo

1:20:20

Foro 'Quo Vadis Perú 2025'

1:22:55

Mi Tienda en Línea en el 2022

0:15:35

UFC Classic: Yoel Romero vs Paulo Costa | FULL FIGHT

0:02:04

Ibrutinib monotherapy in WM: long-term follow-up data